Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.35
0.086.30%
At close: Nov 14, 4:00 PM EST
$1.31
-0.04-2.96%
After Hours: Nov 14, 7:56 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy InflaRx (IFRX) stock?
You can purchase shares of InflaRx (NASDAQ:IFRX) through any online brokerage.
Who are InflaRx (IFRX) competitors?
Other companies in InflaRx’s space includes: Fortress Biotech Inc (NASDAQ:FBIO), Estrella Immunopharma Inc (NASDAQ:ESLA), Adverum Biotechnologies Inc (NASDAQ:ADVM), Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) and Connect Biopharma Holdings Ltd (NASDAQ:CNTB).
What is the forecast, or price target, for InflaRx (IFRX) stock?
InflaRx has a consensus price target of $11.33.
What is the current price for InflaRx (IFRX)?
The stock price for InflaRx (NASDAQ: IFRX) is $1.31 last updated November 14, 2025 at 7:56 PM EST.
Does InflaRx (IFRX) pay a dividend?
There are no upcoming dividends for InflaRx.
When is InflaRx (NASDAQ:IFRX) reporting earnings?
InflaRx does not have any upcoming earnings scheduled.
Is InflaRx (IFRX) going to split?
There is no upcoming split for InflaRx.
What sector and industry does InflaRx (IFRX) operate in?
InflaRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
